glp-1 vs sglt2 weight loss Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on Inhibitors Combining glucagon-like peptide-1 receptor agonists

The Hims and Hers online clinics are designed to be hands-off, but that may be a pro or con depending on what level of support you need

Ten seconds feels long when you are holding a needle in your body, but it is essential for complete dose delivery

Do the math on the aggregate value: multiply the number of spins by the coin size, factor in volatility, and set expectations accordingly

The leading explanation, supported by preclinical work, is that glucagon-receptor agonism drives degradation of PCSK9, which in turn increases hepatic LDL-receptor availability and clears circulating LDL

Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans

The study, Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists, was published on September 25, 2025 in the JAMA